Liposomes in dermatology today

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 5, 2009, Pages 505-516

  De Leeuw, J ^a,c   De Vijlder, H C ^c   Bjerring, P ^b   Neumann, H A M ^c  

^a ZBC MultiCare   (Netherlands)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Dermatology; Drug carriers; Liposomes; Selective drug targeting

Indexed keywords

AMINOLEVULINIC ACID; BENZOYL PEROXIDE; CALCIPOTRIOL; CALCITRIOL; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN A; DITHRANOL; HYDROCORTISONE; ISOTRETINOIN; KHELLIN; LIPOSOME; LIPOXOME; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; PETROLATUM; PHOSPHOLIPID; RETINOIC ACID; TACALCITOL; TRIAMCINOLONE HEXACETONIDE; UNCLASSIFIED DRUG;

ACNE; ACNE VULGARIS; ACTINIC KERATOSIS; ATOPIC DERMATITIS; ATOPY; BASAL CELL CARCINOMA; CLINICAL TRIAL; DESQUAMATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TRANSPORT; EDEMA; ERYTHEMA; ESTHETIC SURGERY; HUMAN; ICHTHYOSIS VULGARIS; IRRITANT DERMATITIS; NEPHROTOXICITY; NONHUMAN; PAIN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN ALLERGY; SKIN IRRITATION; SQUAMOUS CELL CARCINOMA; THROMBOPHLEBITIS; UNSPECIFIED SIDE EFFECT; VITILIGO; XEROSIS;

DERMATOLOGY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES;

EID: 63849185735     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03100.x     Document Type: Review

References (120)

1. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Dermatology, 2nd edn. Springer-Verlag, New York, 2000 chapter 69 : 1719 1721.
2. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965 13 : 238 252.
3. Schmid MH, Korting HC. Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Del Rev 1996 18 : 335 342.
4. Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 1994 15 : 215 220.
5. Hope MJ, Kitson CN. Liposomes: a perspective for dermatologists. Dermatol Clin 1993 11 : 143 154.
6. Egbaria K, Weiner N. Liposomes as a drug delivery system. Adv Drug Del Rev 1990 5 : 287 300.
7. Cullis PR, Hope MJ. Physical properties and functional roles of lipids in membranes. In : Vance DE, Vance JE, eds. Biochemistry of Lipids and Membranes. Benjamin, Cummings Publishing Co., Inc., MenloPark, CA, 1985 : 25 72.
8. Gabrijelcic V, Sentjurc M, Kristl J. Evaluation of liposomes as drug carriers into the skin by one-dimensional EPR imaging. Int J Pharm 1990 62 : 75 79.
9. El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008 34 : 203 222.
10. Mozafari MR. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett 2005 10 : 711 719.
11. Mozafari MR, Reed CJ, Rostron C. Development of non-toxic liposomal formulations for gene and drug delivery to the lung. Technol Health Care 2002 10 : 342 344.
12. McGrath JA, Uitto J. The filaggrin story. novel insights into skin barrier function and disease. Trends Mol Med 2008 14 : 20 27.
13. Elias PM. Epidermal lipids, membranes and keratinization. Int J Dermatol 1981 20 : 1 19.
14. Schürer NY, Plewig G, Elias PM. Stratum corneum lipid function. Dermatologica 1991 183 : 77 94.
15. Imokawa G, Akasaki S, Minematsu Y, Kawai M. Importance of intercellular lipids in water-retention properties of the stratum corneum: induction and recovery study of surfactant dry skin. Arch Dermatol Res 1989 281 : 45 51.
16. Fartach M. Epidermal barrier in disorders of the skin. Micr Res Techn 1997 38 : 361 371.
17. Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Invest Dermatol 1991 96 : 495 499.
18. Artmann C, Roding J, Ghyczy M, Prazel HG. Liposomes from soya phospholipids as percutaneous drug carriers. Arzneim Forsch 1990 40 : 1365 1368.
19. Junginger HE, Hofland HE, Bouwstra JA. Liposomes and niosomes: Interactions with human skin. Cosmetics Toiletries 1991 106 : 45.
20. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin. permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 1996 13 : 257 388.
21. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transepidermal osmotic gradients and hydration force. Biochim Biophys Acta 1992 1104 : 226 232.
22. Lieb L, Ramachandran C, Egbaria K, Weiner N. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units. In vitro evaluation using fluorescent techniques with hamster ear model. J Invest Dermat 1992 99 : 108 113.
23. Hoffman RM. Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. J Drug Target 1998 5 : 67 74.
24. Bernard E, Bubois JL, Wepeirre J. Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. J Pharm Sci 1997 86 : 573 578.
25. Plessis J, Egbaria K, Weiner N. Influence of formulation factors on the deposition of liposomal components into the different strata of the skin. J Soc Cosmet Chem 1992 43 : 93 100.
26. Yarosh D, Bucana C, Cox P, Alas L, Kibitel J, Kripke M. Localization of liposomes containing a DNA repair enzyme in murine skin. J Invest Dermatol 1994 103 : 461 468.
27. Ostro M. Liposomes. Sci Am 1987 256 : 102 111.
28. Yarosh D, Klein J. The role of liposomal delivery in cutaneous DNA repair. Adv Drug Delivery Rev 1996 18 : 325 333.
29. Mezei M, Gulasekharam V. Liposomes - a selective drug delivery system for the topical route of administration: lotion dosage form. Life Sci 1980 26 : 1473 1477.
30. Mezei M, Gulasekharam V. Liposomes - a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 1982 34 : 473 474.
31. Gesztes A, Mezei M. Topical anaesthesia of the skin by liposome-encapsulated tetracaine. Anesth Analg 1988 67 : 1079 1081.
32. Wohlrab W, Lasch J. Penetration kinetics of liposomal hydrocortisone in human skin. Dermatologica 1987 174 : 18 22.
33. Wohlrab W, Lasch J. The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. Dermatol Monatschr 1989 175 : 348 352.
34. Artmann C, Roding J, Ghyczy M. Influence of various liposome preparations on skin humidity. Parfum Kosm 1990 90 : 326.
35. Neugebauer D. Liposomen: Neues therapeutisches princip bei ekzemen und psoriasis. Apotheker J 1993 6 : 20 26.
36. Honzak L, Sentjurc M. Development of liposome encapsulated clindamycin for treatment of acne vulgaris. Eur J Physiol 2000 440 (Suppl 44 45.
37. Schäfer-Korting M, Korting HC, Ponce-Pöschl E. Liposomal tretinoin for uncomplicated acne vulgaris. Clin Invest 1994 72 : 1086 1091.
38. Patel VB, Misra AN, Marfatia YS. Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm Dev Technol 2000 5 : 455 464.
39. Patel VB, Misra AN, Marfatia YS. Preparation and comparative clinical evaluation of liposomal gel of benzoylperoxide for acne. Drug Dev Ind Pharm 2001 27 : 863 870.
40. Fluhr JW, Barsom O, Gehring W, Gloor M. Antibacterial efficacy of benzoylperoxide in phopholipid liposomes. A vehicle-controlled, comparative study in patients with papulopustular acne. Dermatology 1999 198 : 273 277.
41. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Carter LN. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol 2004 3 : 15 19.
42. Santos MA, Belo VG, Santos G. Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: comparative study. Dermatol Surg 2005 31 : 910 915.
43. Hörfelt C, Stenquist B, Larkö O, Faergemann J, Wennberg AM. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action. Acta Derm Venereol 2007 87 : 325 329.
44. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol 2006 54 : 647 651.
45. Christiansen K, Bjerring P, Troilius A. 5-ALA for photodynamic photorejuvenation-optimization of treatment regime based on normal-skin fluorescence measurements. Lasers Surg Med 2007 39 : 302 310.
46. Klein A, Babilas P, Karrer S, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology - an update 2008. J Dtsch Dermatol Ges 2008 6 : 1 7.
47. Irvine AD, McLean WHI. Breaking the (un) sound barrier: Filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 2006 126 : 1200 1202.
48. Palmer CNA, Irvine AD, Terron-Kwiatkowski A, Zhao Y. Common loss-of-function variants of the epidermal barrier protein filaggrin are major predisposing factor for atopic dermatitis. Nat Genet 2006 38 : 441 446.
49. Fartasch M, Bassukas ID, Diepgen TL. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 1992 127 : 221 227.
50. Lee JH, Lee SJ, Kim DS, Bang D. The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2007 21 : 1360 1368.
51. Lautenschlager H. Liposomes in dermatological preparations. Part 1 Cosmet Toiletries 1990 105 : 89 96.
52. Sveinsson SJ, Olafsson JH, Valgardsson VS. The effect of liposomal moisturizing cream on dry skin: a preliminary double-blind study. J Dermatol Treatment 1993 4 : 187 189.
53. Korting HC, Zienicke H, Schafer-Korting M, Braun-Falco O. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol, 1990 39 : 349 351.
54. Lebwohl M. Psoriasis. Lancet 2003 361 : 1197 1204.
55. Krueger G, Ellis CN. Psoriasis-recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 2005 53 : s94 s100.
56. Körbel JN, Sebök B, Kerényl M, Mahrle G. Enhancement of the antiparakeratotic potency of calitriol and tacalcitol in liposomal preparations in the mouse tail test. Skin Pharmacol Appl Skin Physiol 2001 14 : 291 295.
57. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharmac 2001 228 : 43 52.
58. Saraswat A, Agarwal R, Katare OP, Kaur I, Kumar B. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis. J Dermatol Treat 2007 18 : 40 45.
59. Verma DD, Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. J Control Release 2004 97 : 55 66.
60. Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharmaceutics 2004 270 : 119 125.
61. Patel HM. Dermatologic ointment. UK Patent 1984 GB 2 143 : 433A.
62. Moghimi SM, Patel HM. Current progress and future prospects of liposomes in dermal drug delivery. J Microencaps 1993 10 : 155 162.
63. Cui J, Shen L, Wang G. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991 97 : 410 416.
64. Ortel B, Tanew A, Honingsman H. treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 1988 18 : 693 701.
65. Orechia G, Sangalli ME, Gazzaniga A, Giordano F. Topical photochemotherapy of vitiligo with a new khellin formulation: preliminary results. J Dermatol Treatm 1998 9 : 65 69.
66. De Leeuw J, van der Beek N, Maierhofer G, Neugebauer WD. A case study to evaluate the treatment of vitiligo with khellin encapsulated in 1-phenylalanin stabilized phophatidylcholine liposomes in combination with ultraviolet light therapy. Eur J Dermat 2003 13 : 474 477.
67. Kraemer K. Sunlight and skin cancer. Proc Natl Acad Sci USA 1997 94 : 11 14.
68. Dahl E, Aberg M, Rausing A, Rausing EL. Basal cell carcinoma. Cancer 1992 70 : 104 108.
69. Glogau R. The risk of progression to invasive disease. J Am Acad Dermatol 2000 42 : s23 s24.
70. De Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JWW. Predictions of skin cancer incidence in the Netherlands up to 2015. B J Dermatol 2005 152 : 481 488.
71. Ananthaswamy HN, Pierceall WE. Molecular mechanism of ultraviolet radiation carcinogenesis. Photochem Photobiol 1990 52 : 19 136.
72. Tanaka K, Sekiguchi M, Okada Y. Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentation cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus) Proc Natl Acad Sci USA 1975 72 : 4071 4075.
73. Yarosh D. Liposome-encapsulated enzymes for DNA repair. In : Braun-Falco O, Korting H, Maibach H, eds. Liposome Dermatics. Springer-Verlag, Berlin, 1992 : 258 268.
74. Yarosh D, Tsimis J, Yee V. Enhancement of DNA repair of UV damage in mouse and human skin by liposomes containing a DNA repair enzyme. J Soc Cosmet Chem 1990 41 : 85 92.
75. Wolf P, Maier H, Müllegger R. Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-α. J Invest Dermatol 2000 114 : 149 156.
76. Bito T, Ueda M, Nagano T, Fujii S, Ichihashi M. Reduction of ultraviolet-induced skin cancer in mice by topical application of DNA excision repair enzymes. Photodermatol Photoimmunol Photomed 1995 11 : 9 13.
77. Cleaver J. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968 218 : 652 656.
78. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Lancet 2001 357 : 926 929.
79. Lowe NJ, Lowe PL. A pilot study to determine the efficacy of ALA-PDT photorejuvenation for the treatment of facial aging. J Cos Laser Ther 2005 7 : 159 162.
80. Kim HS, Yoo JY, Cho KH, Kwon OS, Moon SE. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: Clinical and histopathologic evaluation. Dermatol Surg 2005 31 : 33 36.
81. Vinciullo C, Elliott T, Francis D et al. Photodynamic therapy with topical methylaminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 2005 152 : 765 772.
82. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004 30 : 264 271.
83. Britton JE, Goulden V, Stables G, Stringer M, Sheehan-Dare R. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Br J Dermatol 2005 153 : 780 784.
84. De Rosa FS, Bentley MVLB. Photodynamic therapy of skin cancers. sensitizers, clinical studies and future. Pharm Res 2000 17 : 1447 1455.
85. Casas A, Batlle A. Aminolevulinic acid derivates and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy. Curr Med Chem 2006 13 : 1157 1168.
86. Kloek J, Akkermans W, van Henegouwen GMJB. Derivates of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 1998 67 : 150 154.
87. Pierre MBR, Tedesco AC, Marchetti JM, Bentley MVLB. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol 2001 1 : 1 5.
88. Oppel T, Korting HC. Actinic keratosen: the key event in the evolution from photoaged skin to squamous cell carcinoma. Skin Pharmacol Physiol 2004 17 : 67 76.
89. Panjehpour M, Julius CE, Phan MN, Vo-Dihn T, Overholt S. Laser-induced fluorescence spectroscopy for in vivo diagnosis of non-melanoma skin cancers. Lasers Surg Med 2002 31 : 367 373.
90. Aghassi D, Anderson RR, Gonzalez S. Confocal laser microscopic imaging of actinic keratosis in vivo: a preliminary report. J Am Acad Dermatol 2000 43 : 42 48.
91. Smits T, Kleinpenning MM, Blokx WAM, van der Kerkhof PCM, van Erp PEJ, Gerritsen MJP. Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. J Am Acad Dermatol 2007 57 : 824 831.
92. Kleinpenning MM, Smits T, Ewalds E, van Erp PEJ, van de Kerkhof PCM, Gerritsen MJP. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study. Br J Dermatol 2006 155 : 539 545.
93. Gorty S, Patton-Adkins J, Dalanno M. Superficial venous thrombosis of the lower extremities. Analysis of risk factors, and recurrence and role of anticoagulation. Vasc Med 2004 9 : 1 6.
94. Katzenschlager R, Hirschl M, Minar E, Ugurlouglu A. Liposomal heparin-spray gel in comparison with subcutaneous low molecular weight heparin in patients with superficial venous thrombosis. A randomized, controlled, open multicentre study. J Kardiol 2003 10 : 375 378.
95. Katzenschlager R, Ugurlouglu A, Sipos G, Bihari I. Efficacy and tolerability of liposomal heparin spray gel as an add-on treatment in the management of superficial venous thrombosis. Angiology 2007 58 (Suppl. 1 27s 35s.
96. Sand M, Bechara FG, Sand D, Altmeyer P, Hoffmann K. A randomized, controlled, double-blind study evaluating melanin-encapsulated liposomes as a chromophore for laser hair removal of blond, white, and grey hair. Ann Plast Surg 2007 58 : 551 554.
97. Tierney E, Goldberg DJ. Laser hair removal pearls. J Cosm Laser Ther 2008 10 : 17 23.
98. De Leeuw J, van der Beek N, Neugebauer D. Permanent hair removal of white, grey and light blond hair after laser treatment combined with melanin encapsulated liposomes. URL: http://www.lipoxome.com (medical studies 2002).
99. Chattinakorn K. A prospective study analyzing the effects of pretreatment topical melanin in liposome compared with long pulsed Nd: Yag laser alone for hair removal. J Am Acad Dermatol 2007 56 (Suppl. 2 AB203.
100. Taddio A, Kaur Soin H, Schuh S, Koren G, Scolni D. Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ 2005 172 : 1691 1695.
101. Hallen B, Calsson P, Uppfeldt A. Clinical study of lignocaine-prilocaine cream to relieve pain of venepuncture. Br J Anaesth 1985 57 : 326 328.
102. Sims C. Thickly and thinly applied lignocaine-prilocaine cream prior to venepuncture in children. Anaesth Intens Care 1991 19 : 343 345.
103. Eichenfield LF, Funk A, Fallon-Friedlander S, Cunningham BB. A clinical study to evaluate the efficacy of ELA-Max (4% liposomal lidocaine) as compared with eutectic mixture of local anesthetics cream for pain reduction of venepuncture in children. Pediatrics 2002 109 : 1093 1099.
104. Koh JL, Harrison D, Myers R, Dembinski R, Turner H, McGraw T. A randomized, double-blind comparison study of EMLA and ELA-Max for topical anesthesia in children undergoing intravenous insertion. Pediatr Anaesth 2004 14 : 977 982.
105. Fisher R, Hung O, Mezei M, Stewart R. Topical anaesthesia of intact skin: liposome-encapsulated tetracaine vs EMLA. Br J Anaesth 1998 81 : 972 973.
106. Gold MH. Photodynamic therapy with lasers and intense pulsed light. Facial Plast Surg Clin N Am 2007 15 : 145 160.
107. Biter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000 26 : 835 842.
108. Alster TS, Tanzi EL, Welsh CW. Photorejuvenation of facial skin with 20% 5-aminolevulinic acid and intense pulsed light. J Drug Dermatol 2005 4 : 35 38.
109. Gold MH, Bradshaw VL, Boring MM. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermat Surg 2006 32 : 795 801.
110. Touma D, Yaar M, Whitehead S. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004 140 : 33 40.
111. Olsen EA, Katz HI, Levine N. Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol 1992 26 : 215 224.
112. Lippman SM, Meyskens FL. Results of the use of vitamin A and retinoids in cutaneous malignancies. Pharmac Ther 1989 40 : 107 122.
113. Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Controlled Rel 2005 103 : 123 136.
114. Banerjee R. Liposomes: Applications in Medicine. J Biomater Appl 2001 16 : 3 21.
115. Barry BW. Penetration enhancers. In : Shroot B, Schäffer H, eds. Skin Pharmacokinetics. Karger, Basel, 1987 : 121 127.
116. Dreher F, Walde P, Luist PL, Elsner P. Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes. Skin Pharmacol 1996 9 : 124 129.
117. Patel H. Liposomes as a controlled-release system. Biochem Soc Trans 1985 13 : 513 516.
118. Date AA, Naik B, Nagarsenker MS. Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 2006 19 : 2 16.
119. Brisaert M, Gabriëls M, Matthijs V, Plaizier-Vercammen J. Liposomes with tretinoin: a physical and chemical evaluation. J Pharm Biomed Anal 2001 26 : 909 917.
120. Yarosh D, Klein J, Kibitel J. Enzyme therapy of xeroderma pigmentosum: safety and efficacy of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme. Photodermatol Photoimmunol Photomed 1996 12 : 122 130.